Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
38.82
-0.96 (-2.41%)
Jul 17, 2026, 2:24 PM EDT - Market open
Axogen Market Cap
Axogen has a market cap or net worth of $2.06 billion as of July 17, 2026. Its market cap has increased by 283.45% in one year.
Market Cap
2.06B
Enterprise Value
2.03B
1-Year Change
283.45%
Ranking
Category
Stock Price
$38.82
ChartMarket Cap Chart
Since December 1, 1998, Axogen's market cap has increased from $12.20M to $2.06B, an increase of 16,818.83%. That is a compound annual growth rate of 20.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.06B | 36.73% |
| Dec 31, 2025 | 1.51B | 108.13% |
| Dec 31, 2024 | 725.30M | 146.70% |
| Dec 29, 2023 | 294.00M | -30.33% |
| Dec 30, 2022 | 422.00M | 8.37% |
| Dec 31, 2021 | 389.40M | -45.79% |
| Dec 31, 2020 | 718.30M | 1.73% |
| Dec 31, 2019 | 706.10M | -10.63% |
| Dec 31, 2018 | 790.10M | -16.55% |
| Dec 29, 2017 | 946.80M | 219.76% |
| Dec 30, 2016 | 296.10M | 98.19% |
| Dec 31, 2015 | 149.40M | 113.43% |
| Dec 31, 2014 | 70.00M | -10.14% |
| Dec 31, 2013 | 77.90M | 159.67% |
| Dec 31, 2012 | 30.00M | 1.35% |
| Dec 30, 2011 | 29.60M | 97.33% |
| Dec 31, 2010 | 15.00M | -12.79% |
| Dec 31, 2009 | 17.20M | 45.76% |
| Dec 31, 2008 | 11.80M | 118.52% |
| Dec 31, 2007 | 5.40M | 100.00% |
| Dec 29, 2006 | 2.70M | 28.57% |
| Dec 30, 2005 | 2.10M | -65.00% |
| Dec 31, 2004 | 6.00M | 87.50% |
| Dec 31, 2003 | 3.20M | 60.00% |
| Dec 31, 2002 | 2.00M | -60.78% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransMedics Group | 2.58B |
| Establishment Labs Holdings | 2.55B |
| Neogen | 2.10B |
| Butterfly Network | 2.03B |
| NovoCure | 1.80B |
| UFP Technologies | 1.78B |
| Integra LifeSciences Holdings | 1.43B |
| Enovis | 1.42B |